Merck Announces a New Covid Pill

By Radiant Health Editors

Published: October 3, 2021

Health News Briefs

The pharmaceutical company Merck announced it would soon seek emergency use authorization for its new pill, molnupiravir, to treat Covid-19. In studies conducted on people who recently contracted the virus, the experimental drug cut hospitalizations and deaths in half. The pill must be taken within five days of the appearance of symptoms, and it did not appear to help those who are already severely ill.

Download your free digital edition of Radiant at radianthealthmag.com/free.

Radiant is a biannual print and digital health magazine dedicated to the Black woman. Download a free digital edition at radianthealthmag.com/free.

Some Americans Will Have Medical Debt Wiped From Credit

The three major credit reporting companies, Equifax, Experian, and TransUnion, will no longer include paid medical debt in their credit ... read more
Health News Briefs
Natural Gas Used to Heat Homes Contains Some Harmful Chemicals

A new study published in the journal Environmental Science & Technology has found that several dangerous cancer-causing chemicals are present ... read more
Health News Briefs
Uterine Cancer Claims Many Black Lives

Instances of endometrial cancer, also known as uterine cancer, are on the rise, especially among Black women. Cancer of the ... read more
Health News Briefs
Babies and Toddlers Get COVID-19 Shots

The CDC has approved Pfizer’s and Moderna’s COVID-19 vaccines for America’s youngest citizens. Children as young as six months will ... read more
Health News Briefs